BIOMARIN PHARMACEUTICAL INC Human Resources Contracts & Agreements
79 Contracts & Agreements
- Bonus & Incentive Agreements (13 contracts)
- Compensation Agreements (10)
- Consulting Agreements (3)
- Employment Agreements (39)
- Separation Agreements (2)
- Severance Agreements (8)
- Transition Agreements (4)
- BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on August 5, 2024)
- Amendment, dated as of June 8, 2024, to the Consulting Agreement by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (Filed With SEC on August 5, 2024)
- Employment Agreement by and between BioMarin Pharmaceutical Inc. and Alexander Hardy, dated October 30, 2023 (Filed With SEC on November 3, 2023)
- Consulting Agreement by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (Filed With SEC on November 3, 2023)
- Separation Agreement and General Release by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (Filed With SEC on November 3, 2023)
- BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as amended on April 3, 2023 (Filed With SEC on August 2, 2023)
- Form of Stock Options Agreement for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)
- Form of Agreement Regarding Restricted Stock Units for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)
- BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 28, 2022)
- Second Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted October 4, 2022 (Filed With SEC on October 28, 2022)
- Second amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted on October 5, 2021 (Filed With SEC on February 25, 2022)
- Part-Time Employment Agreement with Robert A. Baffi, Ph.D. effective January 1, 2021 (Filed With SEC on February 26, 2021)
- BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 29, 2019)
- BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as adopted April 10, 2017 and amended April 12, 2019 (Filed With SEC on August 2, 2019)
- First Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted June 4, 2019 (Filed With SEC on August 2, 2019)
- BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 31, 2017)
- BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) Agreement Regarding Performance Stock Awards in the Form of Restricted Stock Units (Filed With SEC on June 12, 2017)
- BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) Agreement Regarding Restricted Stock Units (Filed With SEC on June 12, 2017)
- BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) STOCK OPTIONS AGREEMENT (Filed With SEC on June 12, 2017)
- FIRST AMENDMENT TO THE AMENDED AND RESTATED Termination and Transition Agreement (Filed With SEC on February 27, 2017)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 19, 2016)
- BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (as amended and restated on April 16, 2015) (the Plan) Form of Amendment to Agreement Regarding Restricted Share Units (Filed With SEC on December 9, 2016)
- TERMINATION AND TRANSITION AGREEMENT by and between BioMarin Pharmaceutical Inc., a Delaware corporation, and Ares Trading S.A. 1 (Filed With SEC on February 29, 2016)
- AMENDED AND RESTATED TERMINATION AND TRANSITION AGREEMENT by and between BioMarin Pharmaceutical Inc., a Delaware corporation, and Ares Trading S.A. 1 (Filed With SEC on February 29, 2016)
- AMENDED AND RESTATED TERMINATION AND TRANSITION AGREEMENT by and between BIOMARIN PHARMACEUTICAL INC., a Delaware corporation, and ARES TRADING S.A. - 1 - (Filed With SEC on January 7, 2016)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 15, 2015)
- BIOMARIN PHARMACEUTICAL INC. 2006 SHARE INCENTIVE PLAN (As amended and restated on April 16, 2015) PLAN DOCUMENT (Filed With SEC on June 15, 2015)
- AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN... (Filed With SEC on October 14, 2014)
- BIOMARIN PHARMACEUTICAL INC. Amended and Restated Severance Plan and Summary Plan Description Amended and Restated Effective October 7, 2014 (Filed With SEC on October 14, 2014)
- AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN... (Filed With SEC on May 2, 2014)
- BIOMARIN PHARMACEUTICAL INC. Amended and Restated Severance Plan and Summary Plan Description Amended and Restated Effective July 29, 2013 (the Effective Date) (Filed With SEC on July 30, 2013)
- BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (thePlan) Agreement Regarding Restricted Stock Units (Filed With SEC on May 16, 2013)
- AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)
- SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on September 5, 2012)
